US6770666B2
(en)
*
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
RU2223761C2
(ru)
*
|
1999-12-27 |
2004-02-20 |
Джапан Тобакко Инк. |
Соединения с конденсированным кольцом и их использование в качестве лекарственных средств
|
US6448281B1
(en)
*
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
US20020165781A1
(en)
*
|
2000-10-31 |
2002-11-07 |
Mckay Brent |
Interactive media management system and method for network applications
|
AU2002219555B2
(en)
|
2000-12-28 |
2006-11-30 |
Daiichi Pharmaceutical Co., Ltd. |
VLA-4 Inhibitors
|
ATE402164T1
(de)
*
|
2001-04-26 |
2008-08-15 |
Eisai R&D Man Co Ltd |
Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon
|
US7030150B2
(en)
*
|
2001-05-11 |
2006-04-18 |
Trimeris, Inc. |
Benzimidazole compounds and antiviral uses thereof
|
AR035543A1
(es)
*
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
US6841566B2
(en)
|
2001-07-20 |
2005-01-11 |
Boehringer Ingelheim, Ltd. |
Viral polymerase inhibitors
|
EP2335700A1
(fr)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
|
US7294457B2
(en)
*
|
2001-08-07 |
2007-11-13 |
Boehringer Ingelheim (Canada) Ltd. |
Direct binding assay for identifying inhibitors of HCV polymerase
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
PL213029B1
(pl)
|
2002-05-20 |
2012-12-31 |
Bristol Myers Squibb Co |
Podstawiona pochodna cykloalkilowa, zawierajaca ja kompozycja oraz ich zastosowanie
|
DE60334205D1
(en)
|
2002-05-20 |
2010-10-28 |
Bristol Myers Squibb Co |
Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
|
ES2361011T3
(es)
|
2002-05-20 |
2011-06-13 |
Bristol-Myers Squibb Company |
Inhibidores del virus de la hepatitis c.
|
TW200400963A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
|
TW200400818A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
|
WO2003101993A1
(fr)
*
|
2002-06-04 |
2003-12-11 |
Neogenesis Pharmaceuticals, Inc. |
Composes de pyrazolo(1,5a)pyrimidine servant d'agents antiviraux
|
WO2004002977A1
(fr)
*
|
2002-07-01 |
2004-01-08 |
Pharmacia & Upjohn Company Llc |
Inhibiteurs de la polymerase ns5b du vhc
|
AU2003256335A1
(en)
|
2002-07-01 |
2004-01-19 |
Pharmacia And Upjohn Company |
Inhibitors of hcv ns5b polymerase
|
GB0215293D0
(en)
|
2002-07-03 |
2002-08-14 |
Rega Foundation |
Viral inhibitors
|
US6812363B2
(en)
*
|
2002-10-15 |
2004-11-02 |
Usv Limited |
Racemization of optically active 2-substituted phenyl glycine esters
|
AU2003286776A1
(en)
*
|
2002-10-30 |
2004-06-07 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
US7902203B2
(en)
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
US7151114B2
(en)
|
2003-01-09 |
2006-12-19 |
Boehringer Ingelheim International Gmbh |
Use of substituted 2-phenylbenzimidazoles as medicaments
|
US7098231B2
(en)
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
GB0307891D0
(en)
*
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
ES2320771T3
(es)
|
2003-04-16 |
2009-05-28 |
Bristol-Myers Squibb Company |
Inhibidores peptidicos de isoquinolina macrociclicos del virus de la hepatitis c.
|
KR101164070B1
(ko)
*
|
2003-05-09 |
2012-07-12 |
베링거 인겔하임 인터내셔날 게엠베하 |
C형 간염 바이러스 ns5b 폴리머라제 억제제 결합 포켓
|
SE0301446D0
(sv)
|
2003-05-16 |
2003-05-16 |
Astrazeneca Ab |
New Compounds
|
CA2528044A1
(fr)
*
|
2003-06-04 |
2004-12-16 |
Genelabs Technologies, Inc. |
Derives heteroaryles contenant de l'azote
|
TWI340134B
(en)
|
2003-07-24 |
2011-04-11 |
Daiichi Seiyaku Co |
Cyclohexanecarboxylic acids
|
KR20060054410A
(ko)
*
|
2003-08-01 |
2006-05-22 |
제네랩스 테크놀로지스, 인코포레이티드 |
플라비비리다에에 대한 2고리 이미다졸 유도체
|
WO2005014543A1
(fr)
*
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
Compose a cycle condense utilise comme inhibiteur de la polymerase du vhc
|
US7442709B2
(en)
|
2003-08-21 |
2008-10-28 |
Osi Pharmaceuticals, Inc. |
N3-substituted imidazopyridine c-Kit inhibitors
|
UA82395C2
(en)
*
|
2003-08-21 |
2008-04-10 |
Оси Фармасьютикалз, Инк. |
N-substituted benzimidazolyl c-kit inhibitors
|
AU2004268948A1
(en)
|
2003-08-21 |
2005-03-10 |
Osi Pharmaceuticals, Inc. |
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
|
GB0321003D0
(en)
|
2003-09-09 |
2003-10-08 |
Angeletti P Ist Richerche Bio |
Compounds, compositions and uses
|
US7112601B2
(en)
|
2003-09-11 |
2006-09-26 |
Bristol-Myers Squibb Company |
Cycloalkyl heterocycles for treating hepatitis C virus
|
CA2540858C
(fr)
|
2003-10-14 |
2009-12-08 |
Intermune, Inc. |
Acylsulfonamides et acides carboxyliques macrocycliques utilises en tant qu'inhibiteurs de la replication du virus de l'hepatite c
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
US7132504B2
(en)
|
2003-11-12 |
2006-11-07 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7135462B2
(en)
|
2003-11-20 |
2006-11-14 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7309708B2
(en)
|
2003-11-20 |
2007-12-18 |
Birstol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EP1694671A2
(fr)
|
2003-12-04 |
2006-08-30 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines utiles comme inhibiteurs des proteines kinases
|
US20050222198A1
(en)
*
|
2003-12-22 |
2005-10-06 |
K.U. Leuven Research & Development, Gerhard Puerstinger And Gilead Sciences, Inc. |
Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
|
EP1730167B1
(fr)
|
2004-01-21 |
2011-01-12 |
Boehringer Ingelheim International GmbH |
Peptides macrocycliques actifs contre le virus de l'hepatite c
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
NZ549079A
(en)
*
|
2004-02-20 |
2010-08-27 |
Boehringer Ingelheim Int |
Viral polymerase inhibitors
|
US20070049593A1
(en)
|
2004-02-24 |
2007-03-01 |
Japan Tobacco Inc. |
Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
|
EP2206715A1
(fr)
|
2004-02-24 |
2010-07-14 |
Japan Tobacco, Inc. |
Composé héterotétracycliques fusionnés et leur utilisation en tant qu'inhibiteurs de la polymérase du HCV
|
US7618981B2
(en)
*
|
2004-05-06 |
2009-11-17 |
Cytokinetics, Inc. |
Imidazopyridinyl-benzamide anti-cancer agents
|
AU2005254057B2
(en)
|
2004-06-15 |
2011-02-17 |
Isis Pharmaceuticals, Inc. |
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
|
US7429604B2
(en)
*
|
2004-06-15 |
2008-09-30 |
Bristol Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
BRPI0512360A
(pt)
*
|
2004-06-23 |
2008-03-11 |
Idenix Cayman Ltd |
derivados de 5-aza-7-deazapurina para o tratamento de flaviviridae
|
JP2008504280A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
2−メチルプロパンアミドおよびその医薬としての使用
|
UY29017A1
(es)
*
|
2004-07-16 |
2006-02-24 |
Boehringer Ingelheim Int |
Inhibidores de polimerasa viral
|
BRPI0513811A
(pt)
|
2004-07-27 |
2008-07-15 |
Gilead Sciences Inc |
imidazo [4,5-d] pirimidinas, seus usos e processos de preparação
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
JP2006077004A
(ja)
*
|
2004-08-11 |
2006-03-23 |
Chugai Pharmaceut Co Ltd |
抗hcv作用を有する化合物およびそれを含む医薬組成物
|
DE102004054054A1
(de)
*
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
US7659263B2
(en)
|
2004-11-12 |
2010-02-09 |
Japan Tobacco Inc. |
Thienopyrrole compound and use thereof as HCV polymerase inhibitor
|
CN101103018A
(zh)
*
|
2004-11-16 |
2008-01-09 |
神经化学(国际)有限公司 |
治疗cns和淀粉样蛋白-相关疾病的化合物
|
CN101193867A
(zh)
*
|
2004-12-01 |
2008-06-04 |
Osi医药有限公司 |
N取代的苯并咪唑基c-Kit抑制剂和苯并咪唑组合库
|
CA2592388C
(fr)
*
|
2004-12-21 |
2013-04-02 |
Steven S. Bondy |
Compose d'imidazo[4,5-c]pyridine et traitement antiviral dans lequel est utilise ledit compose
|
US7638491B2
(en)
*
|
2004-12-22 |
2009-12-29 |
Ambrx, Inc. |
Therapies using non-natural amino acids and polypeptides
|
MX2007008587A
(es)
*
|
2005-01-14 |
2007-09-07 |
Genelabs Tech Inc |
Derivados de indol para tratamiento de infecciones virales.
|
WO2006093801A1
(fr)
|
2005-02-25 |
2006-09-08 |
Abbott Laboratories |
Derives de thiadiazine utiles en tant qu’agents anti-infectieux
|
JP2008535790A
(ja)
*
|
2005-03-03 |
2008-09-04 |
サートリス ファーマシューティカルズ, インコーポレイテッド |
サーチュインモジュレーターであるn−フェニルベンズアミド誘導体
|
JP2008540370A
(ja)
|
2005-05-04 |
2008-11-20 |
エフ.ホフマン−ラ ロシュ アーゲー |
ヘテロ環式抗ウイルス化合物
|
US7470664B2
(en)
|
2005-07-20 |
2008-12-30 |
Merck & Co., Inc. |
HCV NS3 protease inhibitors
|
EP1913016B1
(fr)
|
2005-08-01 |
2013-01-16 |
Merck Sharp & Dohme Corp. |
Peptides macrocycliques en tant qu inhibiteurs de la protéase ns3 du vhc
|
AU2006278505B2
(en)
|
2005-08-04 |
2013-01-17 |
Sirtris Pharmaceuticals, Inc. |
Benzothiazoles and thiazolopyridines as sirtuin modulators
|
US8088928B2
(en)
*
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US7855289B2
(en)
*
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US8093401B2
(en)
*
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
US8076365B2
(en)
*
|
2005-08-12 |
2011-12-13 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
GB0518390D0
(en)
*
|
2005-09-09 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
US20090215857A1
(en)
*
|
2005-09-13 |
2009-08-27 |
Pfizer Products Inc. |
Therapeutic Pyrrolidines
|
JP2009001495A
(ja)
*
|
2005-10-13 |
2009-01-08 |
Taisho Pharmaceutical Co Ltd |
2−アリール−ベンゾイミダゾール−5−カルボキサミド誘導体
|
PT1954710E
(pt)
|
2005-11-08 |
2011-06-07 |
Ambrx Inc |
Aceleradores para a modificação de aminoácidos nãonaturais e polipeptídeos de aminoácidos não-naturais
|
AU2006326404B2
(en)
|
2005-12-14 |
2011-11-03 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
ES2395386T3
(es)
|
2005-12-21 |
2013-02-12 |
Abbott Laboratories |
Compuestos antivirales
|
WO2007076035A2
(fr)
|
2005-12-21 |
2007-07-05 |
Abbott Laboratories |
Composes antiviraux
|
ES2378473T3
(es)
|
2005-12-21 |
2012-04-12 |
Abbott Laboratories |
Compuestos antivirales
|
EP2345652A1
(fr)
|
2005-12-21 |
2011-07-20 |
Abbott Laboratories |
Composées antivirales
|
AR058705A1
(es)
*
|
2005-12-23 |
2008-02-20 |
Astrazeneca Ab |
Compuestos de bencimidazol como inhibidores del receptor vaniloide 1 (vr1)
|
ES2395392T3
(es)
*
|
2005-12-29 |
2013-02-12 |
Lexicon Pharmaceuticals, Inc. |
Derivados aminoácidos multicíclicos y métodos de su uso
|
US7816348B2
(en)
*
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
DK2038275T3
(da)
*
|
2006-07-07 |
2010-05-10 |
Gilead Sciences Inc |
Ny pyridazinforbindelse og anvendelse heraf
|
US20080051384A1
(en)
*
|
2006-07-14 |
2008-02-28 |
Genelabs Technologies, Inc. |
Antiviral agents
|
WO2008011337A1
(fr)
|
2006-07-19 |
2008-01-24 |
Abbott Laboratories |
Inhibiteurs du vhc
|
EP1886685A1
(fr)
|
2006-08-11 |
2008-02-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Méthodes, utilisations et compositions pour la modulation de la réplication du HCV par activation ou inhibition du récepteur farnesoid X
|
TWI433839B
(zh)
*
|
2006-08-11 |
2014-04-11 |
Neomed Inst |
新穎的苯并咪唑衍生物290
|
CN101506167A
(zh)
|
2006-08-17 |
2009-08-12 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
MY145314A
(en)
|
2006-10-10 |
2012-01-13 |
Medivir Ab |
Hcv nucleoside inhibtor
|
CA2667165A1
(fr)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Inhibiteurs de la protease hcv ns3
|
CN101583372A
(zh)
|
2006-10-24 |
2009-11-18 |
默克公司 |
Hcv ns3蛋白酶抑制剂
|
WO2008051475A2
(fr)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Inhibiteurs de la protéase ns3 du vhc
|
AU2007318165B2
(en)
|
2006-10-27 |
2011-11-17 |
Msd Italia S.R.L. |
HCV NS3 protease inhibitors
|
ES2444575T3
(es)
|
2006-10-27 |
2014-02-25 |
Merck Sharp & Dohme Corp. |
Inhibidores de la proteasa NS3 del VHC
|
US8101595B2
(en)
|
2006-12-20 |
2012-01-24 |
Istituto di Ricerche di Biologia Molecolare P. Angletti SpA |
Antiviral indoles
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
WO2008133753A2
(fr)
|
2006-12-20 |
2008-11-06 |
Abbott Laboratories |
Composés antiviraux
|
WO2008085508A2
(fr)
|
2007-01-05 |
2008-07-17 |
Merck & Co., Inc. |
Phosphoramidates d'aryle nucléosidiques destinés au traitement de l'infection virale d'arn arn dépendante
|
CN101679437B
(zh)
|
2007-03-13 |
2013-04-17 |
百时美施贵宝公司 |
环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂
|
CN102872461A
(zh)
|
2007-05-04 |
2013-01-16 |
弗特克斯药品有限公司 |
用于治疗hcv感染的组合治疗
|
TW200916472A
(en)
*
|
2007-06-20 |
2009-04-16 |
Sirtris Pharmaceuticals Inc |
Sirtuin modulating compounds
|
EP2162431B1
(fr)
|
2007-06-29 |
2017-06-07 |
Gilead Sciences, Inc. |
Composés antiviraux
|
JP5465667B2
(ja)
|
2007-06-29 |
2014-04-09 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス化合物
|
UA99466C2
(en)
|
2007-07-06 |
2012-08-27 |
Гилиад Сайенсиз, Инк. |
Crystalline pyridazine compound
|
CN101754970B
(zh)
|
2007-07-17 |
2013-07-10 |
P.安杰莱蒂分子生物学研究所 |
用于治疗丙型肝炎的大环吲哚衍生物
|
JP5433573B2
(ja)
|
2007-07-19 |
2014-03-05 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ |
抗ウイルス剤としての大環状化合物
|
WO2009018656A1
(fr)
*
|
2007-08-03 |
2009-02-12 |
Boehringer Ingelheim International Gmbh |
Inhibiteurs de polymerase virale
|
CA2693997C
(fr)
*
|
2007-08-03 |
2013-01-15 |
Pierre L. Beaulieu |
Inhibiteurs de polymerase virale
|
US9149463B2
(en)
|
2007-09-18 |
2015-10-06 |
The Board Of Trustees Of The Leland Standford Junior University |
Methods and compositions of treating a Flaviviridae family viral infection
|
US9101628B2
(en)
|
2007-09-18 |
2015-08-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and composition of treating a flaviviridae family viral infection
|
WO2009039248A2
(fr)
|
2007-09-18 |
2009-03-26 |
Stanford University |
Méthodes de traitement d'une infection par un virus de la famille des flaviviridae et compositions pour le traitement d'une infection par un virus de la famille des flaviviridae
|
US8940730B2
(en)
|
2007-09-18 |
2015-01-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions of treating a Flaviviridae family viral infection
|
US20110039847A1
(en)
*
|
2007-11-01 |
2011-02-17 |
Sirtris Pharmaceuticals, Inc |
Amide derivatives as sirtuin modulators
|
JP2011503066A
(ja)
*
|
2007-11-08 |
2011-01-27 |
サートリス ファーマシューティカルズ, インコーポレイテッド |
可溶化チアゾロピリジン誘導体
|
WO2009062308A1
(fr)
*
|
2007-11-16 |
2009-05-22 |
Boehringer Ingelheim International Gmbh |
Inhibiteurs de la réplication du virus de l'immunodéficience humaine
|
MX2010006210A
(es)
|
2007-12-05 |
2010-08-10 |
Enanta Pharm Inc |
Inhibidores de serina proteasa de hcv de tripeptido fluorado.
|
WO2009076747A1
(fr)
*
|
2007-12-19 |
2009-06-25 |
Boehringer Ingelheim International Gmbh |
Inhibiteurs de polymérase virale
|
JP5574982B2
(ja)
*
|
2008-02-04 |
2014-08-20 |
イデニク プハルマセウティカルス,インコーポレイテッド |
大環状セリンプロテアーゼ阻害剤
|
AU2009241445A1
(en)
|
2008-04-28 |
2009-11-05 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
KR101313675B1
(ko)
|
2008-07-22 |
2013-10-02 |
이스티투토 디 리세르쉐 디 비올로지아 몰레콜라레 피. 안젤레티 에스.알.엘. |
Hcv ns3 프로테아제 억제제로서의 마크로사이클릭 퀴녹살린 화합물
|
US7906655B2
(en)
*
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
KR20110042116A
(ko)
|
2008-08-11 |
2011-04-22 |
글락소스미스클라인 엘엘씨 |
알레르기성, 염증성 및 감염성 질환의 치료에서 사용하기 위한 푸린 유도체
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
LT2320905T
(lt)
|
2008-08-11 |
2017-09-11 |
Glaxosmithkline Llc |
Naujieji adenino dariniai
|
WO2010039801A2
(fr)
|
2008-10-02 |
2010-04-08 |
The J. David Gladstone Institutes |
Méthodes de traitement d’une infection par le virus de l’hépatite c
|
BRPI0922364A2
(pt)
|
2008-12-03 |
2017-08-29 |
Presidio Pharmaceuticals Inc |
Composto, composição farmacêutica e uso de um composto
|
AU2009322393B2
(en)
|
2008-12-03 |
2017-02-02 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
WO2010071853A1
(fr)
|
2008-12-19 |
2010-06-24 |
Sirtris Pharmaceuticals, Inc. |
Composés thiazolopyridines de modulation des sirtuines
|
RU2011127080A
(ru)
|
2009-01-07 |
2013-02-20 |
Сайнексис, Инк. |
Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич
|
EP2385951A4
(fr)
|
2009-01-09 |
2013-05-29 |
Univ Cardiff |
Dérivés de phosphoramidate de composés guanosine nucléoside pour le traitement d'infections virales
|
WO2010082050A1
(fr)
|
2009-01-16 |
2010-07-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Composés benzoxazocines substitués 7-aminoalkyle macrocycycliques destinés au traitement des infections par hépatite c
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
TWI438200B
(zh)
*
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
TW201035083A
(en)
|
2009-03-06 |
2010-10-01 |
Hoffmann La Roche |
Heterocyclic antiviral compounds
|
WO2010107739A2
(fr)
|
2009-03-18 |
2010-09-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Méthodes et compositions pour traiter l'infection par un virus de la famille des flaviviridae
|
BRPI1012282A2
(pt)
|
2009-03-27 |
2015-09-22 |
Presidio Pharmaceuticals Inc |
inibidores de anel fundidos da hepatite c.
|
CA2758072A1
(fr)
|
2009-04-08 |
2010-10-14 |
Idenix Pharmaceuticals, Inc. |
Inhibiteurs macrocycliques de la serine protease
|
SG175774A1
(en)
|
2009-04-25 |
2011-12-29 |
Hoffmann La Roche |
Heterocyclic antiviral compounds
|
WO2010132163A1
(fr)
|
2009-05-13 |
2010-11-18 |
Enanta Pharmaceuticals, Inc. |
Composés macrocycliques comme inhibiteurs du virus de l'hépatite c
|
MX2011012541A
(es)
|
2009-06-24 |
2012-08-03 |
Hoffmann La Roche |
Compuestos heterociclicos antivirales.
|
WO2011014487A1
(fr)
|
2009-07-30 |
2011-02-03 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de protéase ns3 du virus de l'hépatite c
|
JP2013501068A
(ja)
|
2009-08-05 |
2013-01-10 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
大環状セリンプロテアーゼ阻害剤
|
JP2013505218A
(ja)
|
2009-09-21 |
2013-02-14 |
エフ.ホフマン−ラ ロシュ アーゲー |
複素環式抗ウイルス化合物
|
EP3461855B1
(fr)
|
2009-10-11 |
2020-05-27 |
Rutgers, The State University of New Jersey |
Polymeres biocompatibles pour dispositifs medicaux
|
AU2010314891A1
(en)
|
2009-11-06 |
2012-06-07 |
Vanderbilt University |
Aryl and heteroaryl sulfones as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
CN102713630A
(zh)
|
2009-11-14 |
2012-10-03 |
弗·哈夫曼-拉罗切有限公司 |
用于预测对hcv治疗的快速应答的生物标志物
|
CA2778206A1
(fr)
|
2009-11-21 |
2011-05-26 |
F. Hoffmann-La Roche Ag |
Composes antiviraux heterocycliques
|
SG181104A1
(en)
|
2009-12-02 |
2012-07-30 |
Hoffmann La Roche |
Biomarkers for predicting sustained response to hcv treatment
|
RS53745B1
(en)
|
2010-02-10 |
2015-06-30 |
Glaxosmithkline Llc |
6-AMINO-2 - {[(1S) -1-METYLBUTIL] OKSI} -9- [5- (1-PIPERIDINIL) PENTIL] -7,9-DIHIDRO-8H-PURIN-8-ON-MALEAT
|
US8575340B2
(en)
|
2010-02-10 |
2013-11-05 |
Glaxosmithkline Llc |
Purine derivatives and their pharmaceutical uses
|
US8877707B2
(en)
|
2010-05-24 |
2014-11-04 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
CN103153986B
(zh)
*
|
2010-08-04 |
2014-11-05 |
百时美施贵宝公司 |
丙型肝炎病毒抑制剂
|
WO2012020036A1
(fr)
|
2010-08-13 |
2012-02-16 |
F. Hoffmann-La Roche Ag |
Inhibiteurs du virus de l'hépatite c
|
GB201015411D0
(en)
|
2010-09-15 |
2010-10-27 |
Univ Leuven Kath |
Anti-cancer activity of novel bicyclic heterocycles
|
JP5857053B2
(ja)
|
2010-09-21 |
2016-02-10 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
大環式プロリン由来hcvセリンプロテアーゼ阻害剤
|
CN103269586B
(zh)
|
2010-10-26 |
2015-07-15 |
普雷西迪奥制药公司 |
丙型肝炎病毒抑制剂
|
WO2012092484A2
(fr)
|
2010-12-29 |
2012-07-05 |
Inhibitex, Inc. |
Nucléosides puriques substitués, dérivés phosphoramidate et phosphorodiamidate pour le traitement d'infections virales
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
WO2012107589A1
(fr)
|
2011-02-11 |
2012-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Méthodes et compositions pharmaceutiques pour le traitement et la prévention des infections à vhc
|
WO2012123298A1
(fr)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Composés antiviraux
|
WO2012177896A1
(fr)
|
2011-06-24 |
2012-12-27 |
Amgen Inc. |
Antagonistes de trpm8 et leur utilisation dans le cadre thérapeutique
|
WO2012175581A1
(fr)
|
2011-06-24 |
2012-12-27 |
F. Hoffmann-La Roche Ag |
Composés antiviraux
|
US8710043B2
(en)
|
2011-06-24 |
2014-04-29 |
Amgen Inc. |
TRPM8 antagonists and their use in treatments
|
CA2847083A1
(fr)
|
2011-10-10 |
2013-04-18 |
F. Hoffmann-La Roche Ag |
Composes antiviraux
|
US9328138B2
(en)
|
2011-11-15 |
2016-05-03 |
Msd Italia S.R.L. |
HCV NS3 protease inhibitors
|
SG11201402899TA
(en)
|
2011-12-06 |
2014-07-30 |
Univ Leland Stanford Junior |
Methods and compositions for treating viral diseases
|
ES2564906T3
(es)
|
2011-12-16 |
2016-03-29 |
F. Hoffmann-La Roche Ag |
Inhibidores de NS5A del VHC
|
MX350810B
(es)
|
2011-12-20 |
2017-09-20 |
Riboscience Llc |
Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc.
|
PE20141423A1
(es)
|
2011-12-20 |
2014-10-16 |
Hoffmann La Roche |
Derivados nucleosidos con sustitucion 2',4'-difluoro-2'-metilo como inhibidores de la replicacion del arn del vhc
|
US20140356325A1
(en)
|
2012-01-12 |
2014-12-04 |
Ligand Pharmaceuticals Incorporated |
Novel 2'-c-methyl nucleoside derivative compounds
|
EP3312155B1
(fr)
|
2012-02-03 |
2020-08-05 |
Rutgers, The State University of New Jersey |
Biomatériaux polymères dérivés de monomères phénoliques et leurs utilisations médicales
|
US11472918B2
(en)
|
2012-02-03 |
2022-10-18 |
Rutgers, The State University Of New Jersey |
Polymeric biomaterials derived from phenolic monomers and their medical uses
|
JP6092261B2
(ja)
|
2012-02-24 |
2017-03-08 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
抗ウイルス化合物
|
WO2013152039A1
(fr)
|
2012-04-02 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Composés, compositions, et procédés pour moduler la ferroptose et traiter des troubles excitotoxiques
|
US20140010783A1
(en)
|
2012-07-06 |
2014-01-09 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
US8952009B2
(en)
|
2012-08-06 |
2015-02-10 |
Amgen Inc. |
Chroman derivatives as TRPM8 inhibitors
|
JP2015532277A
(ja)
|
2012-09-29 |
2015-11-09 |
ノバルティス アーゲー |
環状ペプチドおよび医薬としてのその使用
|
CN103922999B
(zh)
*
|
2013-01-16 |
2016-05-04 |
上海医药工业研究院 |
一种达比加群酯中间体的制备方法及中间体化合物
|
EP2948440B1
(fr)
|
2013-01-23 |
2017-04-12 |
F. Hoffmann-La Roche AG |
Dérivés de triazole antiviraux
|
WO2014121416A1
(fr)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c
|
WO2014121417A1
(fr)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c
|
WO2014121418A1
(fr)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques tétracycliques et leurs méthodes d'utilisation pour le traitement de l'hépatite c
|
MX2015011193A
(es)
|
2013-03-05 |
2015-11-13 |
Hoffmann La Roche |
Compuestos antivirales.
|
CN104030977B
(zh)
*
|
2013-03-07 |
2016-05-04 |
上海医药工业研究院 |
一种达比加群酯中间体的制备方法
|
RU2534613C2
(ru)
|
2013-03-22 |
2014-11-27 |
Александр Васильевич Иващенко |
Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
|
UA123533C2
(uk)
|
2013-05-16 |
2021-04-21 |
Рібосаєнс Ллс |
4'-фтор-2'-метилзаміщені нуклеозидні похідні
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
WO2014193663A1
(fr)
|
2013-05-16 |
2014-12-04 |
Riboscience Llc |
Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués
|
CN105980365B
(zh)
|
2014-02-11 |
2019-06-21 |
拜耳医药股份公司 |
作为mIDH1抑制剂的苯并咪唑-2-胺
|
CU24410B1
(es)
|
2014-02-11 |
2019-05-03 |
Bayer Pharma AG |
Benzimidazol-2-aminas como inhibidores de midh1
|
JP2017512183A
(ja)
|
2014-02-13 |
2017-05-18 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
CA2938476A1
(fr)
|
2014-02-20 |
2015-08-27 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Derives de pyrrolo[3,2-d]pyrimidine comme inducteurs d'interferon humain
|
US9994600B2
(en)
|
2014-07-02 |
2018-06-12 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and uses therof
|
CN107108554B
(zh)
|
2014-10-23 |
2020-11-06 |
德国癌症研究中心 |
作为midh1抑制剂用于治疗肿瘤的1-环己基-2-苯基氨基苯并咪唑
|
WO2016062677A1
(fr)
|
2014-10-23 |
2016-04-28 |
Bayer Pharma Aktiengesellschaft |
Benzimidazol-2-amines en tant qu'inhibiteurs midh1
|
MX2017006302A
(es)
|
2014-11-13 |
2018-02-16 |
Glaxosmithkline Biologicals Sa |
Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
|
US10774030B2
(en)
|
2014-12-23 |
2020-09-15 |
Rutgers, The State University Of New Jersey |
Polymeric biomaterials derived from phenolic monomers and their medical uses
|
AU2015370426B2
(en)
|
2014-12-23 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Biocompatible iodinated diphenol monomers and polymers
|
EP3971169A1
(fr)
|
2015-04-30 |
2022-03-23 |
Oregon State University |
Procedé pour la production, dans une cellule, d'une protéine ou d'un polypéptide comprennant un amino acide tetrazine
|
AU2016264958B2
(en)
*
|
2015-05-21 |
2020-10-29 |
Glaxosmithkline Intellectual Property Development Limited |
Benzoimidazole derivatives as PAD4 inhibitors
|
CA2988356A1
(fr)
|
2015-06-08 |
2016-12-15 |
Bayer Pharma Aktiengesellschaft |
N-menthylbenzimidazoles a titre d'inhibiteurs de midh1
|
JP6824952B2
(ja)
*
|
2015-07-07 |
2021-02-03 |
ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ |
mIDH1阻害剤としての2−アリール−および2−アリールアルキル−ベンズイミダゾール
|
WO2017009325A1
(fr)
|
2015-07-16 |
2017-01-19 |
Bayer Pharma Aktiengesellschaft |
5-hydroxyalkylbenzimidazoles en tant qu'inhibiteurs de midh1
|
MX363780B
(es)
|
2015-12-03 |
2019-04-03 |
Glaxosmithkline Ip Dev Ltd |
Dinucleótidos de purina cíclica como moduladores del estimulador de los genes de interferón.
|
WO2017175156A1
(fr)
|
2016-04-07 |
2017-10-12 |
Glaxosmithkline Intellectual Property Development Limited |
Amides hétérocycliques utiles en tant que modulateurs de protéine
|
HRP20220936T1
(hr)
|
2016-04-07 |
2022-10-28 |
Glaxosmithkline Intellectual Property Development Limited |
Heterociklički amidi korisni kao modulatori proteina
|
AU2017382360B2
(en)
|
2016-12-23 |
2022-07-28 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use
|
GB201701087D0
(en)
|
2017-01-23 |
2017-03-08 |
Univ Leuven Kath |
Novel prodrugs of mizoribine
|
CN111194217B
(zh)
|
2017-09-21 |
2024-01-12 |
里伯赛恩斯有限责任公司 |
作为hcv rna复制抑制剂的4’-氟-2’-甲基取代的核苷衍生物
|
EP3692033A1
(fr)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Modulateurs de stimulateur des gènes (sting) d'interféron utiles dans le traitement du vih
|
CN111417630B
(zh)
|
2017-10-05 |
2023-06-06 |
葛兰素史克知识产权开发有限公司 |
干扰素基因刺激因子(sting)的调节剂
|
CN107602495B
(zh)
*
|
2017-10-13 |
2018-07-24 |
盐城工学院 |
一种制备手性氨基酸四氮唑类化合物的方法
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
EP3891508A1
(fr)
|
2018-12-04 |
2021-10-13 |
Bristol-Myers Squibb Company |
Procédés d'analyse utilisant une courbe d'étalonnage dans un échantillon par surveillance de réaction d'isotopologues multiples
|
CN109942452B
(zh)
*
|
2019-03-01 |
2021-10-29 |
浙江工业大学 |
一种络氨酸烯烃化衍生物及其制备与应用
|
EP3969438A1
(fr)
|
2019-05-16 |
2022-03-23 |
Stingthera, Inc. |
Dérivés d'acide oxoacridinyle acétique et procédés d'utilisation
|
US20220251079A1
(en)
|
2019-05-16 |
2022-08-11 |
Stingthera, Inc. |
Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
CN110467539B
(zh)
*
|
2019-08-30 |
2023-01-06 |
浙江普洛家园药业有限公司 |
一种2,6-二甲基酪氨酸酯的拆分方法及其应用
|
TW202348228A
(zh)
|
2022-02-24 |
2023-12-16 |
德商艾斯巴赫生物有限公司 |
病毒組合療法
|